<sup>18</sup>F-FDG PET/CT in the Management of Osteosarcoma.
Where this comes from
- Record sourced from PubMed, PMID 37201958.
- Also identified by DOI 10.2967/jnumed.123.265592.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Osteosarcoma is the most common type of primary malignant bone tumor. <sup>18</sup>F-FDG PET/CT is useful for staging, detecting recurrence, monitoring response to neoadjuvant chemotherapy, and predicting prognosis. Here, we review the clinical aspects of osteosarcoma management and assess the role of <sup>18</sup>F-FDG PET/CT, in particular with regard to pediatric and young adult patients.
Medical subject headings
- Bone Neoplasms
- Osteosarcoma